Caplin Point Laboratories Ltd

Caplin Point Laboratories Ltd | Sector: Pharmaceuticals | ISIN: INE475E01026

₹ 592.00 (1.34%) icon

29 Mar, 2023, 3:30:01 PM
₹ 588.20
Prev. Close
₹ 584.15
₹ 928.58
Day's High
₹ 600.00
Day's Low
₹ 575.00
52 Wk High
₹ 856.80
52 Wk Low
₹ 575.00
Book Value
₹ 146.32
Face Value
₹ 2.00
Mkt. Cap (Cr.)
₹ 4,493.44
Div. Yield

Stock View

info icon
Edit Image


Target | 21 Feb, 2023

907.5 (53.16%)

Caplin Point Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in producing, developing, and marketing a range of generic formulations and branded product... Read More


No Record Found

Corporate Actions

30 March , 2023 | 11:17 AM


Indian: 68.80%

Foreign: 0%


Institutions: 3.36%

Non-Institutions: 27.84%


Custodies: 0.00%

See More Details

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Caplin Point Laboratories Ltd News and Update

Article Image
  • 27 March, 2023 |
  • 4:08 PM

The valuation of the company was estimated to be up to $3 billion.

Image not found
  • IIFL News Service |
  • 24 March, 2023 |
  • 4:03 PM
Article Image
ad IconAd Image



Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Caplin Point Laboratories Ltd

  • C C Paarthipan

  • Chairman (Non-Executive)
  • V Thirumalai

  • Non-Exec. & Independent Dir.
  • Sridhar Ganesan

  • Managing Director
  • R Viswanathan

  • Non-Exec. & Independent Dir.
  • D Sathyanarayanan

  • Non-Exec. & Independent Dir.
  • C K Gariyali

  • Non-Exec. & Independent Dir.
  • G Venkatram

  • Company Sec. & Compli. Officer


Promoted by Mr. C. C. Paarthipan, Caplin Point Laboratories Limited was incorporated on April 16th, 1990. The Company is a fully integrated Pharma Company and is presently into the business of pharmaceuticals like producing, developing and marketing wide range of generic formulations and branded products and exporting to overseas market. Its main research and development facilities are located in Tamil Nadu, India and has a manufacturing plant in Puducherry, India. It has over 4000+ products registrations across the globe with over 650+ pharmaceutical formulations & over 36 therapeutic sections.Caplin markets a wide spectrum of pharmaceutical formulations and therapeutic segments in 23 countries. In addition to LATAM and Africa, it is now serving the US, European Union and other regulated markets as well. It manufactures products one among which is for injectables approved inter-alia by EU-GMP, INVIMA, Colombia, Anvisa, Brazil and US FDA. Besides these, it has extended to regulated markets like USA (plans for Canada, Australia, China and Brazil).The company came out with a public issue in Nov.94 and expanded its production capacity by setting up a new unit to manufacture its range of products, at Pondicherry. The company has retained its SSI status even after the expansion and thus will be out of the purview of the DPCO. During 1993-94, Triwin (a partnership firm) was merged with Caplin Point. The company entered into a technical agreement with American Remedies and Concord... Read More

Reports by Caplin Point Laboratories Ltd

Reports by Caplin Point Laboratories Ltd